Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Light therapy on the brain shows promise for treating brain diseases and improving brain function.

There have been major advances in diagnosing and treating hair loss over the last 30 years, with new drugs and improved hair transplant techniques.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.

Sumatriptan injections, high-flow oxygen, and verapamil effectively treat cluster headaches.

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

Anti-androgen drugs can help reduce OCD symptoms, but more large-scale trials are needed to confirm their effectiveness.

New therapies and personalized approaches improve wound healing and patient quality of life.

Tinea capitis in older adults is often misdiagnosed but can be effectively treated with antifungal therapy.

Low-dose oral minoxidil can help treat male and female pattern hair loss, especially in those who can't use topical treatments or have heart health issues.

Doctors need to be better prepared to assess and treat obesity in patients.

Manage women's cholesterol with diet, exercise, and careful treatment choices, especially during pregnancy, PCOS, and menopause.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Stress can worsen skin conditions by affecting hormone levels and immune response.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Ferulic acid may help control menstrual cycle-related epilepsy by affecting female hormones.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

The statement offers guidance for hormone therapy and surgery to help gender-incongruent adults affirm a male identity.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

Western diet may cause male pattern baldness; low glycemic diet with magnesium could help.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.